Authors: Polonis, VR De Souza, MS Chanbancherd, P Chantakulkij, S Jugsudee, A Loomis-Price, LD Vancott, TC Garner, R Markowitz, LE Brown, AE Birx, DL

Citation: Vr. Polonis et al., HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies, AIDS RES H, 17(1), 2001, pp. 69-79

Authors: O'Hagan, DT Ugozzoli, M Barackman, J Singh, M Kazzaz, J Higgins, K Vancott, TC Ott, G

Citation: Dt. O'Hagan et al., Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1, VACCINE, 18(17), 2000, pp. 1793-1801

Authors: Beyrer, C Vancott, TC Peng, NK Artenstein, A Duriasamy, G Nagaratnam, M Saw, TL Hegerich, PA Loomis-Price, LD Hallberg, PL Ettore, CA Nelson, KE

Citation: C. Beyrer et al., HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996, AIDS RES H, 14(18), 1998, pp. 1687-1691